Twenty-year Experience with Genitourinary Lymphoma at a Community Hospital.

Autor: Vallatharasu Y; Department of Medical Education, Gundersen Health System, La Crosse, Wisconsin, USA; Current Affiliation: Thedacare Regional Cancer Center, Appleton, Wisconsin, USA., Chennamadhavuni A; Department of Medical Education, Gundersen Health System, La Crosse, Wisconsin, USA; Current Affiliation: Hematology/Oncology Fellow at University of Iowa Health Care, Iowa City, Iowa, USA., Van Every MJ; Department of Urology, Gundersen Health System, La Crosse, Wisconsin, USA marvvanevery@icloud.com.

Publikováno v: Clinical medicine & research [Clin Med Res] 2021 Jun; Vol. 19 (2), pp. 72-81. Date of Electronic Publication: 2021 Mar 31.

Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting Agents.

Autor: Valsasina, Barbara¹ (AUTHOR) barbara.valsasina@nervianoms.com, Orsini, Paolo¹ (AUTHOR), Terenghi, Chiara² (AUTHOR), Ocana, Alberto^3,4,5 (AUTHOR)

Publikováno v: Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1338. 22p.

Sequential treatment failures in response to BRAF/MEK and immune checkpoint inhibitors mediated by MAP2K2 and B2M mutations in melanoma.

Autor: Richmond CS; Kabara Cancer Research Institute, Gundersen Medical Foundation, 1300 Badger Street, La Crosse, WI 54601, USA., Vallatharasu Y; Department of Medical Education, Gundersen Health System, La Crosse, WI 54601, USA., Deviley JA; Department of Oncology, Gundersen Health System, La Crosse, WI 54601, USA., Vos CR; Kabara Cancer Research Institute, Gundersen Medical Foundation, 1300 Badger Street, La Crosse, WI 54601, USA., Parsons BM; Department of Oncology, Gundersen Health System, La Crosse, WI 54601, USA., Kenny PA; Kabara Cancer Research Institute, Gundersen Medical Foundation, 1300 Badger Street, La Crosse, WI 54601, USA; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA. Electronic address: pakenny@gundersenhealth.org.

Publikováno v: Experimental and molecular pathology [Exp Mol Pathol] 2019 Oct; Vol. 110, pp. 104260. Date of Electronic Publication: 2019 May 11.

Severe, prolonged thrombocytopenia in a patient sensitive to exenatide.

Autor: Vallatharasu Y; Department of Hematology and Medical Oncology, Gundersen Health System, La Crosse, Wisconsin., Hayashi-Tanner Y; Department of Hematology and Medical Oncology, Gundersen Health System, La Crosse, Wisconsin., Polewski PJ; Department of Hematology and Medical Oncology, Gundersen Health System, La Crosse, Wisconsin., Bottner WA; Department of Hematology and Medical Oncology, Gundersen Health System, La Crosse, Wisconsin., Rosenstein LJ; Department of Hematology and Medical Oncology, Gundersen Health System, La Crosse, Wisconsin., Uprety D; Department of Hematology and Medical Oncology, Gundersen Health System, La Crosse, Wisconsin., Bista A; Department of Hematology and Medical Oncology, Gundersen Health System, La Crosse, Wisconsin., Farnen JP; Department of Hematology and Medical Oncology, Gundersen Health System, La Crosse, Wisconsin., Aster R; BloodCenter of Wisconsin, Blood Research Institute, Milwaukee, Wisconsin.; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

Publikováno v: American journal of hematology [Am J Hematol] 2019 Mar; Vol. 94 (3), pp. E78-E80. Date of Electronic Publication: 2018 Dec 28.

The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor-Mutated Stage IIIB or IV Non-Small-Cell Lung Cancer Patients.

Autor: Uprety D; Department of Hematology & Medical Oncology, Gundersen Health System, La Crosse, WI, USA., Bista A; Gundersen Lutheran Medical Center, Gundersen Health System, La Crosse, WI, USA., Vallatharasu Y; Gundersen Lutheran Medical Center, Gundersen Health System, La Crosse, WI, USA., Arjyal L; Gundersen Lutheran Medical Center, Gundersen Health System, La Crosse, WI, USA.

Publikováno v: Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2018 Jun 04; Vol. 12, pp. 1179554918779585. Date of Electronic Publication: 2018 Jun 04 (Print Publication: 2018).